ENHANZE® Drug Delivery Technology | Halozyme, Inc. (NOTE AAPS OPT INS)

Tell Us About Your Subcutaneous (subQ) Drug Development Needs

Choose answers that best describe your opinions and needs. At the end of this survey you'll have an opportunity for any additional comments or questions.

We value your privacy. Responses are for Halozyme use only.

 
1.What information from Halozyme Therapeutics are you most interested in? (select all that apply)(Required.)
2.Are you developing or considering developing subQ formulations of biologics? (select one)(Required.)
3.What is the BIGGEST challenge with subQ drug development? (select one)(Required.)
4.What are the key considerations in deciding to develop a subQ drug? (select all that apply)(Required.)
5.Would you like additional information about ENHANZE® high-dose, high-volume drug delivery technology? (select all that apply)(Required.)
6.First Name(Required.)
7.Last Name(Required.)
8.Title(Required.)
9.Company(Required.)
10.Email(Required.)